Logo image of PDYN

PALLADYNE AI CORP (PDYN) Stock Fundamental Analysis

NASDAQ:PDYN - Nasdaq - US80359A2050 - Common Stock - Currency: USD

7.675  -0.04 (-0.58%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PDYN. PDYN was compared to 128 industry peers in the Machinery industry. While PDYN seems to be doing ok healthwise, there are quite some concerns on its profitability. PDYN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PDYN has reported negative net income.
PDYN had a negative operating cash flow in the past year.
PDYN Yearly Net Income VS EBIT VS OCF VS FCFPDYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -129.09%, PDYN is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -129.09%
ROE N/A
ROIC N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PDYN Yearly ROA, ROE, ROICPDYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 55.20%, PDYN belongs to the top of the industry, outperforming 96.09% of the companies in the same industry.
PDYN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PDYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
PDYN Yearly Profit, Operating, Gross MarginsPDYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K -1.5K

4

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
PDYN has more shares outstanding than it did 1 year ago.
There is no outstanding debt for PDYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PDYN Yearly Shares OutstandingPDYN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
PDYN Yearly Total Debt VS Total AssetsPDYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PDYN has an Altman-Z score of -10.34. This is a bad value and indicates that PDYN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.34, PDYN is doing worse than 91.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.34
ROIC/WACCN/A
WACC9.98%
PDYN Yearly LT Debt VS Equity VS FCFPDYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 9.64 indicates that PDYN has no problem at all paying its short term obligations.
PDYN has a Current ratio of 9.64. This is amongst the best in the industry. PDYN outperforms 96.88% of its industry peers.
A Quick Ratio of 9.62 indicates that PDYN has no problem at all paying its short term obligations.
PDYN's Quick ratio of 9.62 is amongst the best of the industry. PDYN outperforms 96.88% of its industry peers.
Industry RankSector Rank
Current Ratio 9.64
Quick Ratio 9.62
PDYN Yearly Current Assets VS Current LiabilitesPDYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

The earnings per share for PDYN have decreased strongly by -80.81% in the last year.
PDYN shows a strong growth in Revenue. In the last year, the Revenue has grown by 187.07%.
EPS 1Y (TTM)-80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)187.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.29%

3.2 Future

PDYN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.86% yearly.
The Revenue is expected to decrease by -3.87% on average over the next years.
EPS Next Y14.37%
EPS Next 2Y29.69%
EPS Next 3Y20.68%
EPS Next 5Y15.86%
Revenue Next Year-55.65%
Revenue Next 2Y-23.93%
Revenue Next 3Y-24.38%
Revenue Next 5Y-3.86%

3.3 Evolution

PDYN Yearly Revenue VS EstimatesPDYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M
PDYN Yearly EPS VS EstimatesPDYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3

1

4. Valuation

4.1 Price/Earnings Ratio

PDYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PDYN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PDYN Price Earnings VS Forward Price EarningsPDYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDYN Per share dataPDYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

PDYN's earnings are expected to grow with 20.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.69%
EPS Next 3Y20.68%

0

5. Dividend

5.1 Amount

PDYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALLADYNE AI CORP

NASDAQ:PDYN (5/30/2025, 1:44:58 PM)

7.675

-0.04 (-0.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners14.7%
Inst Owner ChangeN/A
Ins Owners33.04%
Ins Owner Change-2.89%
Market Cap274.07M
Analysts82.86
Price Target15.3 (99.35%)
Short Float %9.44%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.75%
Revenue NY rev (1m)4.12%
Revenue NY rev (3m)2.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 35.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.24
EYN/A
EPS(NY)-1.03
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS0.22
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -129.09%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.2%
FCFM N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.12%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.64
Quick Ratio 9.62
Altman-Z -10.34
F-Score6
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)30.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y14.37%
EPS Next 2Y29.69%
EPS Next 3Y20.68%
EPS Next 5Y15.86%
Revenue 1Y (TTM)187.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-50.29%
Revenue Next Year-55.65%
Revenue Next 2Y-23.93%
Revenue Next 3Y-24.38%
Revenue Next 5Y-3.86%
EBIT growth 1Y67.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.54%
EBIT Next 3Y90.23%
EBIT Next 5Y65.6%
FCF growth 1Y70.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.47%
OCF growth 3YN/A
OCF growth 5YN/A